Select your language

Forecast, save and improve lives
Phone LinkedIn

Diagnostic revolution

Early decisions matter

Treat infants individually, specifically and in a timely manner. Prevent negative effects and complications. This is what the new generation of scientifically validated prediction software for obstetrics and neonatology is enabling.


Our breakthrough
prediction tool

Digitize scientific and clinical experience — a paradigm shift in maternal, neonatal and perinatal care. Clinical care of mothers and their children is supported and optimized by our algorithm. This algorithm was trained and validated with the data of thousands of newborns.

The breakthrough prediction tool of NeoPrediX will support decision makers in clinics to optimize care and therapy for each individual patient. In doing so, we will facilitate therapeutic decisions for the most vulnerable patients, the newborns. It is about the moment. The future begins now.

250 Mio.

per year

140 Mio.

per year

14 Mio.

Premature Babies
per year

What we do

The new generation
of analysis software
for neonatology

NeoPrediX develops decision support tools with maternal, neonatal and perinatal screening platforms to evaluate, optimize and personalize medical strategies in pediatrics. We utilize scientifically validated algorithms and digital health solutions for neonatal and perinatal care based on deep medical data and science, developed by experienced scientists, pediatricians, and neonatologists.

Would you like to learn more about our company and our innovations?
We look forward to hearing from you at This email address is being protected from spambots. You need JavaScript enabled to view it.

Our vision

We enhance and personalize healthcare in early life.

Our mission

We transform medical data into scientifically validated predictions to support clinical decisions.

Career Opportunities

Designing the future of medicine. With you.

We are a young, innovative company in the medical technology software field. The company is a spin-off from the University of Basel. A diverse, highly motivated team driven by desire for achievement and passion for children and their families provides an ideal work environment. A high degree of independence and self-organization together with short decision-making paths makes us agile and efficient. We are developing new, individual treatment solutions to enhance perinatal and neonatal care.
Your input is appreciated.

Feel free to send an unsolicited application. We are always looking for experts for our future projects.

Technical Product Manager (all genders)
DevOps Engineer (all genders)
Senior Marketing Manager B2B (all genders)


The team of experts

Experience for progress -
a highly qualified leadership team

Thorsten Waloschek

Senior industry executive

President of Draeger Medical Neonatal Care and Vice President of Draeger Medical USA

Head of marketing and new business development at NATUS

Co-founder of InfanDx

Marc Pfister

Clinician, researcher, innovator and entrepreneur

Head of the department of pharmacometrics at the University Children’s Hospital in Basel, Switzerland

Experience at Sanofi-Aventis, Bristol-Myers Squibb, University of Basel

Jörg Schmidt

Senior financial executive in Life Sciences and MedTech industries

Experience at Ernst & Young

Focus on bringing innovative companies and their products to market successfully

Sven Wellmann

Medical Director Dept. of Neonatology and Perinatal Center Regensburg

Leading researcher

Experience at Charité, UKBB Basel, University of Zurich, University of Regensburg

Sebastian Kässner

Sebastian Kässner
Head of Sales and Marketing

Senior executive with extensive international experience in healthcare sales and marketing

Start-up entrepreneur in healthcare and hygiene management

SLM Solutions, Paul Hartmann AG, NEXTBRAND GmbH, Drager Medical GmbH

Gilbert Koch

Gilbert Koch
Clinical Pharmacologist

Senior Research Fellow in Pediatric Clinical Pharmacology, University of Basel, UKBB

Adjunct Assistant Professor, State University of New York at Buffalo – School of Pharmacy with >10 years of experience in pharmacokinetic and pharmacodynamic modeling


Advisory Board

Julia Vogt

Prof. Julia Vogt
ETH Zurich, Switzerland

Senior industry executive

Professor of Computer Science at ETH Zurich

Expert in machine learning for clinical data analysis and precision medicine

John van den Anker

Prof. John van den Anker
Children’s National Medical Center

Director Chief of Clinical Pharmacology

Professor of Pediatrics at George Washington University

Past Distinguished Professor in Pediatric Pharmacology and Pharmacometrics at the University of Basel Children’s Hospital

Sotirios Fouzas

Prof. Sotirios Fouzas
University of Patras, Greece

Professor of Pediatrics with specialty in pediatric respiratory medicine

Driven to change the way neonatology is currently practiced

Jonathan Palma

Dr. Jonathan Palma
Orlando Health Winnie Palmer Hospital

Doctor of neonatology and perinatal medicine at Winnie Palmer Hospital for Women & Babies (NICU)

Clinical informaticist at Orlando Health

Newborn intensive care and enhancements to patient care quality and provider experience

Supervisory Board

Christine Storm

Christine Storm
Philips, Germany

Senior industry executive

Business leader virtual care solutions

Expertise in scale-up of start ups

 Volker Pfahlert

Dr. Volker Pfahlert


Former CEO of Numares AG (retired) and Draeger Medical

Gerhard Ries

Dr. Gerhard Ries

Serial entrepreneur

CEO Kineo Finance


Arne Kirchner

Arne Kirchner

Founder of Alp Financial Services

Asset management

Investment banking


Contact our team

Contact our innovative team
This email address is being protected from spambots. You need JavaScript enabled to view it.

Please feel free to contact us at any time for further questions and requests.